MYGN vs QDEL
Myriad Genetics Inc. and QuidelOrtho Corp., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | MYGN | QDEL |
|---|---|---|
| Revenue | $824.5M | $2.7B |
| Net income | $-365.9M | $-1.1B |
| Gross margin | 69.9% | 46.7% |
| Net margin | −44.4% | −41.5% |
| Return on equity | −68.5% | −46.1% |
| Diluted EPS | −$3.95 | −$16.69 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | · | $-83.0M |
| Equity | $368.0M | $1.9B |
| Net debt / equity | −0.08× | 1.41× |
| Current ratio | 2.49× | 1.50× |
| Revenue CAGR 5y | 8.2% | 10.4% |
| Profit CAGR 5y | · | · |
QDEL bills 3.3× the revenue of MYGN, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
6 years side by side
| Fiscal year | MYGN | QDEL |
|---|---|---|
| FY2025 | $824.5M | $2.7B |
| FY2024 | $837.6M | $2.8B |
| FY2023 | $753.2M | $3.0B |
| FY2022 | $678.4M | $3.3B |
| FY2021 | $690.6M | $1.7B |
| FY2020 | $557.1M | $1.7B |
Bottom line
| Fiscal year | MYGN | QDEL |
|---|---|---|
| FY2025 | $-365.9M | $-1.1B |
| FY2024 | $-127.3M | $-2.1B |
| FY2023 | $-263.3M | $-10.1M |
| FY2022 | $-112.0M | $548.7M |
| FY2021 | $-27.2M | $704.2M |
| FY2020 | $-223.6M | $810.3M |
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$1,905,700,000 | QDEL |
| FY2024 | −$1,945,300,000 | QDEL |
| FY2023 | −$2,244,600,000 | QDEL |
| FY2022 | −$2,587,600,000 | QDEL |
| FY2021 | −$1,008,000,000 | QDEL |
| FY2020 | −$1,104,600,000 | QDEL |
QDEL has reported the higher revenue in every one of these 6 fiscal years. The gap has widened since the earliest year compared.
6 of 18 comparable fiscal years — a year missing data on either side is not counted.
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −2.9 pp | QDEL |
| FY2024 | +58.5 pp | MYGN |
| FY2023 | −34.6 pp | QDEL |
| FY2022 | −33.3 pp | QDEL |
| FY2021 | −45.4 pp | QDEL |
| FY2020 | −88.9 pp | QDEL |
The higher net margin has changed hands between MYGN and QDEL over this period.
6 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
QDEL's net margin has been more volatile than MYGN's over the 6 comparable fiscal years — 43.8 percentage points of standard deviation against 14.8.
6 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between MYGN and QDEL over these 6 fiscal years — MYGN led in 1 and QDEL in 5.
6 of 18 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
QDEL's return on equity has been more volatile than MYGN's over the 6 comparable fiscal years — 41.8 percentage points of standard deviation against 21.0.
6 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between MYGN and QDEL over these 6 fiscal years — MYGN led in 1 and QDEL in 5.
6 of 18 comparable fiscal years — a year missing data on either side is not counted.